OREANDA-NEWS. December 09, 2015. Dr. Hal Paz, Aetnas Chief Medical Officer, recently published an article on the FierceHealthPayer website describing how the combined clinical capabilities and knowledge of Aetna and Humana will help create more healthy days for members.

The article highlighted clinical programs from both Aetna and Humana that are helping improve care, such as Compassionate Care and Humana at Home. The successful progress of Aetnas collaborative relationship with Inova, a health system based in Northern Virginia, was also featured in the article.

These programs demonstrate tangible ways that Aetna and Humana have already helped improve care on their own, Dr. Paz wrote. Our combined clinical knowledge and capabilities will advance these programs and allow us to innovate collaboratively with more health care professionals. Most importantly for me, and the more than 4,000 clinicians at Aetna, is our enhanced ability to help people have more healthy days.

Dr. Paz explained that in his former roles as a medical school dean, as well as CEO of two medical group practices and a large health system and medical center, he was always proud of the care they provided in their local communities. But while we made the people around us healthier, our impact would always be limited by two factors our geography and the size of our organizations. Aetnas connection with more than 1.1 million healthcare professionals, including more than 675,000 primary care doctors and specialists and 5,600 hospitals, gives us the opportunity to help improve care in more places. Our collaborative relationships with health care professionals  focused on quality of care for patients have improved health outcomes and lowered costs. Our proposed acquisition of Humana will enhance our capabilities and allow us to accelerate the transformation of the healthcare system.

Important information regarding Aetnas acquisition of Humana

October 19, 2015

Cautionary Statement Regarding Forward-Looking Statements

This website contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  You can generally identify forward-looking statements by the use of forward-looking terminology such as anticipate, believe, continue, could, estimate, expect, explore, evaluate, intend, may, might, plan, potential, predict, project, seek, should, or will, or the negative thereof or other variations thereon or comparable terminology.  These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond Aetna Inc.s (Aetnas) and Humana Inc.s (Humanas) control.

Statements in this website regarding Aetna that are forward-looking, including Aetnas projections as to the anticipated benefits of the pending transaction to Aetna, increased membership as a result of the pending transaction, the impact of the pending transaction on Aetnas businesses and share of revenues from Government business, the methods Aetna will use to finance the cash portion of the transaction, the impact of the transaction on Aetnas revenue and operating earnings per share, the synergies from the pending transaction, and the closing date for the pending transaction, are based on managements estimates, assumptions and projections, and are subject to significant uncertainties and other factors, many of which are beyond Aetnas control. In particular, projected financial information for the combined businesses of Aetna and Humana is based on managements estimates, assumptions and projections and has not been prepared in conformance with the applicable accounting requirements of Regulation S-X relating to pro forma financial information, and the required pro forma adjustments have not been applied and are not reflected therein.  None of this information should be considered in isolation from, or as a substitute for, the historical financial statements of Aetna or Humana. Important risk factors could cause actual future results and other future events to differ materially from those currently estimated by management, including, but not limited to: the timing to consummate the proposed acquisition; the risk that a condition to closing of the proposed acquisition may not be satisfied; the risk that a regulatory approval that may be required for the proposed acquisition is delayed, is not obtained or is obtained subject to conditions that are not anticipated; Aetnas ability to achieve the synergies and value creation contemplated by the proposed acquisition; Aetnas ability to promptly and effectively integrate Humanas businesses; the diversion of management time on acquisition-related issues; unanticipated increases in medical costs (including increased intensity or medical utilization as a result of flu or otherwise; changes in membership mix to higher cost or lower-premium products or membership-adverse selection; medical cost increases resulting from unfavorable changes in contracting or re-contracting with providers (including as a result of provider consolidation and/or integration); and increased pharmacy costs (including in Aetnas health insurance exchange products)); the profitability of Aetnas public health insurance exchange products, where membership is higher than Aetna projected and may have more adverse health status and/or higher medical benefit utilization than Aetna projected; uncertainty related to Aetnas accruals for health care reforms reinsurance, risk adjustment and risk corridor programs (3Rs); the implementation of health care reform legislation, including collection of health care reform fees, assessments and taxes through increased premiums; adverse legislative, regulatory and/or judicial changes to or interpretations of existing health care reform legislation and/or regulations (including those relating to minimum MLR rebates); the implementation of health insurance exchanges; Aetnas ability to offset Medicare Advantage and PDP rate pressures; and changes in Aetnas future cash requirements, capital requirements, results of operations, financial condition and/or cash flows.  Health care reform will continue to significantly impact Aetnas business operations and financial results, including Aetnas pricing and medical benefit ratios.  Key components of the legislation will continue to be phased in through 2018, and Aetna will be required to dedicate material resources and incur material expenses during 2015 to implement health care reform.  Certain significant parts of the legislation, including aspects of public health insurance exchanges, Medicaid expansion, reinsurance, risk corridor and risk adjustment and the implementation of Medicare Advantage and Part D minimum medical loss ratios (MLRs), require further guidance and clarification at the federal level and/or in the form of regulations and actions by state legislatures to implement the law.  In addition, pending efforts in the U.S. Congress to amend or restrict funding for various aspects of health care reform, and litigation challenging aspects of the law continue to create additional uncertainty about the ultimate impact of health care reform.  As a result, many of the impacts of health care reform will not be known for the next several years.  Other important risk factors include: adverse changes in health care reform and/or other federal or state government policies or regulations as a result of health care reform or otherwise (including legislative, judicial or regulatory measures that would affect Aetnas business model, restrict funding for or amend various aspects of health care reform, limit Aetnas ability to price for the risk it assumes and/or reflect reasonable costs or profits in its pricing, such as mandated minimum medical benefit ratios, or eliminate or reduce ERISA pre-emption of state laws (increasing Aetnas potential litigation exposure)); adverse and less predictable economic conditions in the U.S. and abroad (including unanticipated levels of, or increases in the rate of, unemployment); reputational or financial issues arising from Aetnas social media activities, data security breaches, other cybersecurity risks or other causes; Aetnas ability to diversify Aetnas sources of revenue and earnings (including by creating a consumer business and expanding Aetnas foreign operations), transform Aetnas business model, develop new products and optimize Aetnas business platforms; the success of Aetnas Healthagen (including Accountable Care Solutions and health information technology) initiatives; adverse changes in size, product or geographic mix or medical cost experience of membership; managing executive succession and key talent retention, recruitment and development; failure to achieve and/or delays in achieving desired rate increases and/or profitable membership growth due to regulatory review or other regulatory restrictions, the difficult economy and/or significant competition, especially in key geographic areas where membership is concentrated, including successful protests of business awarded to Aetna; failure to adequately implement health care reform; the outcome of various litigation and regulatory matters, including audits, challenges to Aetnas minimum MLR rebate methodology and/or reports, guaranty fund assessments, intellectual property litigation and litigation concerning, and ongoing reviews by various regulatory authorities of, certain of Aetnas payment practices with respect to out-of-network providers and/or life insurance policies; Aetnas ability to integrate, simplify, and enhance Aetnas existing products, processes and information technology systems and platforms to keep pace with changing customer and regulatory needs; Aetnas ability to successfully integrate Aetnas businesses (including Humana, Coventry, bswift LLC and other businesses Aetna may acquire in the future) and implement multiple strategic and operational initiatives simultaneously; Aetnas ability to manage health care and other benefit costs; adverse program, pricing, funding or audit actions by federal or state government payors, including as a result of sequestration and/or curtailment or elimination of the Centers for Medicare & Medicaid Services star rating bonus payments; Aetnas ability to reduce administrative expenses while maintaining targeted levels of service and operating performance; failure by a service provider to meet its obligations to us; Aetnas ability to develop and maintain relationships (including collaborative risk-sharing agreements) with providers while taking actions to reduce medical costs and/or expand the services Aetna offers; Aetnas ability to demonstrate that Aetnas products and processes lead to access to quality affordable care by Aetnas members; Aetnas ability to maintain Aetnas relationships with third-party brokers, consultants and agents who sell Aetnas products; increases in medical costs or Group Insurance claims resulting from any epidemics, acts of terrorism or other extreme events; changes in medical cost estimates due to the necessary extensive judgment that is used in the medical cost estimation process, the considerable variability inherent in such estimates, and the sensitivity of such estimates to changes in medical claims payment patterns and changes in medical cost trends; a downgrade in Aetnas financial ratings; and adverse impacts from any failure to raise the U.S. Federal governments debt ceiling or any sustained U.S. Federal government shut down.  For more discussion of important risk factors that may materially affect Aetna, please see the risk factors contained in Aetnas 2014 Annual Report on Form 10-K (Aetnas 2014 Annual Report) and Aetnas Quarterly Report on Form 10-Q for the quarter ended June 30, 2015, on file with the Securities and Exchange Commission (SEC). You should also read Aetnas 2014 Annual Report and Aetnas Quarterly Report on Form 10-Q for the quarter ended June 30, 2015, on file with the SEC, for a discussion of Aetnas historical results of operations and financial condition.  Except as specifically noted, information on, or accessible from, any website to which this website contains a hyperlink is not incorporated by reference into this website and does not constitute a part of this website.

No assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do occur, what impact they will have on the results of operations, financial condition or cash flows of Aetna or Humana.  Neither Aetna nor Humana assumes any duty to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, as of any future date.